Jan 31 (Reuters) - Moderna Inc said on Monday it received full approval from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine for individuals 18 years of age and older. (Reporting by Amruta Khandekar; Editing by Anil D'Silva)